BRAF and melanoma: Similarly, as suggested previously [32], an alternative hypothesis could be that the biology of melanoma is similar to that of other cancers where biology drives mutual exclusivity, for example activation of the MAPK pathway via either BRAF or NRAS mutation, but chance explains most co‐occurrences.